Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities

Yasmine Van CaeneghemDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium

Stijn De MunterDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium

Paola TieppoDepartment of Biopharmacy and Institute for Medical Immunology, Université Libre de Bruxelles (ULB), Brussels, Belgium

Glenn GoetgelukDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium

Karin WeeningDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium

Greet VerstichelDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium

Sarah BonteDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium

Tom TaghonDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium

Georges LeclercqDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium

Tessa KerreDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium

Reno DebetsLaboratory of Tumor Immunology, Department of Medical Immunology, Erasmus MC Cancer Center, Rotterdam, the Netherlands

David VermijlenDepartment of Biopharmacy and Institute for Medical Immunology, Université Libre de Bruxelles (ULB), Brussels, Belgium

Hinrich AbkenCenter for Molecular Medicine Cologne (CMMC) and Department of Internal Medicine, University of Cologne, Cologne, Germany

Bart VandekerckhoveDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, BelgiumCorrespondence[email protected]

Articles from other publishers (13)